Opinion: How Pfizer walked away from Ozempic decades ago

In an alternate reality, generics would be available by now, David Wallace-Wells writes.

View in browser|nytimes.com January 18, 2025 Scientists made a breakthrough that could have led to the development of drugs like Ozempic decades ago, David Wallace-Wells writes. FROM OPINION Ibrahim Rayintakath Instead of pursuing it, Pfizer walked away. → Sign up for the Opinion Today newsletter Get expert analysis of the news and a guide to the big ideas shaping the world every weekday morning. Get it in your inbox Need help? Review our newsletter help page or contact us for assistance. You received this message because you signed up for updates from The New York Times. To stop receiving From The Times, unsubscribe. To opt out of other promotional emails from The Times, including those regarding The Athletic, manage your email settings. To opt out of updates and offers sent from The Athletic, submit a request. Subscribe to The TimesGet The New York Times app Connect with us on: Change Your EmailPrivacy PolicyContact UsCalifornia Notices The New York Times Company. 620 Eighth Avenue New York, NY 10018